S-3ASR
As filed with the Securities and Exchange Commission on November 26, 2008
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AIR PRODUCTS AND CHEMICALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
23-1274455 |
(State or other jurisdiction of
|
|
(I.R.S. Employer |
Incorporation or Organization)
|
|
Identification Number) |
7201 Hamilton Boulevard
Allentown, Pennsylvania 18195-1501
Telephone: (610) 481-4911
(Address, including zip code, and telephone number, including
area code, of registrant=s principal executive offices)
Stephen J. Jones, Esq.
Senior Vice President, General Counsel and Secretary
AIR PRODUCTS AND CHEMICALS, INC.
7201 HAMILTON BOULEVARD
ALLENTOWN, PENNSYLVANIA 18195-1501
Telephone: (610) 481-4911
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies To:
Andrew J. Pitts, Esq.
Cravath, Swaine & Moore LLP
Worldwide Plaza
825 Eighth Avenue
New York, New York 10019
(212) 474-1620
(212) 474-3700 (facsimile)
Approximate date of commencement of proposed sale to public: From time to time after the
effective date of this registration statement.
If the only securities being registered on this Form are being offered pursuant to dividend or
interest reinvestment plans, please check the following box. o
If any of the securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933 (the Securities Act),
other than securities offered only in connection with dividend or interest reinvestment plans,
check the following box. þ
If this Form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities
Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering. o
If this Form is a registration statement pursuant to General Instruction I.D. or a
post-effective amendment thereto that shall become effective upon filing with the Commission
pursuant to Rule 462(e) under the Securities Act, check the following box. þ
If this Form is a post-effective amendment to a registration statement filed pursuant to
General Instruction I.D. filed to register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities Act, check the following box. o
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
Amount to be registered/ |
|
|
|
|
|
Proposed maximum offering price per unit/ |
|
|
|
|
|
Proposed maximum aggregate offering price/ |
|
|
Title of each class of securities to be registered |
|
|
Amount of registration fee |
|
|
Debt Securities |
|
|
|
|
|
Common Stock
Preferred Stock
Warrants |
|
|
|
|
|
Depositary Shares
|
|
|
(1) (2) (3) |
|
|
|
|
|
(1) |
|
An indeterminate aggregate initial offering price or number of the securities of each
identified class is being registered as may from time to time be issued at indeterminate
prices. Separate consideration may or may not be received for securities that are issuable on
exercise, conversion or exchange of other securities. |
|
(2) |
|
Pursuant to Rule 457(p), $56,630 of the filing fees previously paid with respect to
registrants registration statement 333-111792, filed on January 26, 2004, relate to
securities which remain unsold as of this date, and are being offset against registration fees
to become due under all offerings that may be hereinafter be made under this registration
statement. In accordance with Rules 456(b) and 457(r), the registrant is deferring payment of
all other registration fees which may subsequently be payable following application of the
above-referenced pre-paid filing fees. |
|
(3) |
|
Any securities registered hereunder may be sold separately or as units with other securities
registered hereunder. |
The information in this prospectus is not complete and may be changed. We may not sell these
securities until the registration statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these securities and it is not soliciting an
offer to buy these securities in any state where the offer or sale is not permitted.
DATED NOVEMBER 26, 2008
Prospectus
AIR PRODUCTS AND CHEMICALS, INC.
DEBT SECURITIES
PREFERRED STOCK
DEPOSITARY SHARES
COMMON STOCK
WARRANTS
We may offer these securities in one or more offerings. We will provide the specific terms of
these securities in supplements to this prospectus. You should read this prospectus and any
supplement carefully before you invest.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR
DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus is November 26, 2008
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the
SEC. You may read and copy any document we file at the SECs Public Reference Room, 450 Fifth
Street, N.W., Washington, D.C. 20549. You may call the SEC at 1-800-SEC-0330 for further
information on the SECs Public Reference Room. You may also access our SEC filings at the SECs
web site at http://www.sec.gov.
The SEC allows us to incorporate by reference into this prospectus the information we file
with it, which means that we can disclose important information to you by referring you to those
documents. The information incorporated by reference is considered to be part of this prospectus,
and later information that we file with the SEC will automatically update and supersede this
information. We incorporate by reference the documents listed below and any future filings made
with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 until
this offering is completed:
|
|
|
Annual Report on Form 10-K for the year ended
September 30, 2008; |
|
|
|
|
Current Report on Form 8-K dated November 24, 2008; and |
|
|
|
|
the description of our common stock in our Form 8-A that was filed on March
20, 1998. |
You may request a copy of these filings at no cost, by writing to or telephoning us at:
Corporate Secretarys Office
Air Products and Chemicals, Inc.
7201 Hamilton Boulevard
Allentown, Pennsylvania 18195-1501
Telephone: (610) 481-4911
You should rely only on the information incorporated by reference or provided in this
prospectus or the accompanying prospectus supplement. We have not authorized anyone to provide you
with different information. We are not making an offer of these securities in any state where the
offer is not permitted. You should not assume that the information in this prospectus, any
prospectus supplement or any document which we incorporate by reference is accurate as of any date
other than the date on its cover.
THE COMPANY
Air Products is a Delaware corporation originally founded in 1940. We serve technology,
energy, industrial and healthcare customers globally with a unique portfolio of products, services
and solutions that include atmospheric gases, process and specialty gases, performance materials,
equipment and services. We are the worlds largest supplier of hydrogen and helium and have built
leading positions in growth markets such as semiconductor materials, refinery hydrogen, natural gas
liquefaction, and advanced coatings and adhesives. As used in this Report, unless the context
indicates otherwise, the term Company includes subsidiaries and predecessors of the registrant
and its subsidiaries.
On 31 January 2008, we sold our interest in our vinyl acetate ethylene polymers joint ventures
to Wacker Chemie AG, our long time joint venture partner. We completed the sale of our polymers
emulsions business with the sale of our two remaining production facilities in Elkton, Maryland and
Piedmont, South Carolina and the related North American atmospheric emulsions and pressure
sensitive adhesives businesses in June 2008. During fiscal 2008, we sold our high purity process
chemicals business which had previously been reported as part of the
electronics and performance
materials operating segment. In July 2008, our Board of Directors authorized management to pursue
the sale of our U.S. healthcare business; in September 2008, we sold our healthcare business
related to several New York and New Jersey locations and in October 2008 sold our seating and
mobility unit.
Previously, we reported results for a chemicals segment, which consisted of the polymer
emulsions business and the polyurethane intermediates business, and a healthcare segment.
Beginning with the first quarter of 2008, the polymer emulsions business was accounted for as
discontinued operations and the polyurethane intermediates business was reported as part of the
tonnage gases segment. Beginning with the fourth quarter of 2008, the U.S. healthcare business was
accounted for as discontinued operations and the European healthcare business was reported as part
of the merchant gases segment. We now manage our operations, assess
performance and report
2
earnings under four business segments: merchant gases; tonnage gases; electronics and
performance materials; and equipment and energy.
RATIOS OF EARNINGS TO FIXED CHARGES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
YEAR ENDED SEPTEMBER 30, |
|
|
2004 |
|
2005 |
|
2006 |
|
2007 |
|
2008 |
Ratio of earnings to fixed charges |
|
|
6.0 |
|
|
|
6.6 |
|
|
|
6.8 |
|
|
|
7.0 |
|
|
|
7.4 |
|
The ratio of earnings to fixed charges is determined by dividing earnings, which includes
income from continuing operations before taxes, undistributed earnings of
less-than-fifty-percent-owned affiliates, and fixed charges, by fixed charges. Fixed charges
consist of interest on all indebtedness plus that portion of operating lease rentals representative
of the interest factor (deemed to be 21% of operating lease rentals).
USE OF PROCEEDS
Unless otherwise specified in the applicable prospectus supplement, the net proceeds we
receive from the sale of the securities offered by this prospectus and the accompanying prospectus
supplement will be used for general corporate purposes. General corporate purposes may include the
repayment of debt, investments in or extensions of credit to our subsidiaries, redemption of common
stock or preferred stock and the financing of possible acquisitions or business expansion. The net
proceeds may be invested temporarily or applied to repay short-term debt until they are used for
their stated purpose.
3
DESCRIPTION OF SECURITIES
Debt Securities
The following description of the terms of the debt securities sets forth general terms that
may apply to the debt securities. The particular terms of any debt securities will be described in
the prospectus supplement relating to those debt securities.
The debt securities will be our senior debt securities. The debt securities will be issued
under an indenture dated as of January 10, 1995, between us and The Bank of New York Trust Company,
N.A. (formerly, Wachovia Bank, National Association and initially First Fidelity Bank, National
Association), as trustee (the Indenture).
The following is a summary of the most important provisions of the Indenture. A copy of the
Indenture is an exhibit to the registration statement of which this prospectus is a part. Section
references below are to the section in the Indenture. The referenced sections of the Indenture are
incorporated by reference.
General
The Indenture does not limit the amount of debt securities that we may issue. The Indenture
provides that debt securities may be issued up to the principal amount authorized by us from time
to time. The debt securities will be unsecured and will have the same rank as all of our other
unsecured and unsubordinated debt.
The debt securities may be issued in one or more separate series. The prospectus supplement
relating to the particular series of debt securities being offered will specify the particular
amounts, prices and terms of those debt securities. These terms may include:
|
|
|
the title of the debt securities; |
|
|
|
|
any limit upon the aggregate principal amount issued; |
|
|
|
|
the maturity date or dates, or the method of determining the maturity dates; |
|
|
|
|
the interest rate or rates, or the method of determining those rates; |
|
|
|
|
the interest payment dates and the regular record dates; |
|
|
|
|
the places where payments may be made; |
|
|
|
|
any mandatory or optional redemption provisions; |
|
|
|
|
any sinking fund or analogous provisions; |
|
|
|
|
the portion of principal amount of the debt security payable upon
acceleration of maturity if other than the full principal amount; |
|
|
|
|
any deletions of, or changes or additions to, the events of default or
covenants; |
|
|
|
|
the form of the debt securities; |
|
|
|
|
if other than U.S. dollars, the currency or currencies, including composite
currencies, in which payments on the debt securities will be payable and
whether we or a holder may elect payment to be made in a different currency; |
|
|
|
|
the method of determining the amount of any payments on the debt securities
which are linked to an index; |
4
|
|
|
whether the debt securities will be issued in the form of one or more global
securities in temporary or definitive form; |
|
|
|
|
any terms relating to the delivery of the debt securities if they are to be
issued upon the exercise of warrants; |
|
|
|
|
whether and on what terms we will pay additional amounts to holders of the
debt securities that are not U.S. persons in respect of any tax, assessment or
governmental charge withheld or deducted and, if so, whether and on what terms
we will have the option to redeem the debt securities rather than pay the
additional amounts; |
|
|
|
|
any conversion or exchange provisions; |
|
|
|
|
any terms for the attachment to the debt securities of warrants, options or
other rights to purchase or sell our securities; |
|
|
|
|
any special United States Federal income tax or other considerations with
respect to the debt securities; and any other specific terms of the debt
securities. |
|
|
|
|
(Section 2.3) |
Unless otherwise specified in the prospectus supplement, debt securities denominated in U.S.
dollars will be issued in denominations of $1,000 or an integral multiple of $1,000. (Section 2.8)
We may issue some of the debt securities as original issue discount debt securities. Original
issue discount securities bear no interest or bear interest at below-market rates and will be sold
at a discount below their stated principal amount.
Certain Covenants of the Company
Limitation on Liens Subject to the exceptions set forth below under Exempted Indebtedness,
we covenant that we will not create or assume, nor will we permit any Restricted Subsidiary (as
hereinafter defined) to create or assume, any,
|
|
|
mortgage |
|
|
|
|
security interest, |
|
|
|
|
pledge, or |
|
|
|
|
lien |
(together, we refer to these transactions as liens) of or upon any Principal Property (as defined
below), or any underlying real estate of such property, or shares of capital stock or indebtedness
of any Restricted Subsidiary, whether owned at the date of the Indenture or thereafter acquired,
without equally and ratably securing the outstanding debt securities. This restriction will not
apply to certain permitted liens, including the following:
|
(i) |
|
liens on any Principal Property which are
created or assumed contemporaneously with, or within 120 days after (or
in the case of any such Principal Property which is being financed on
the basis of long-term contracts or similar financing arrangements for
which a firm commitment is made by one or more banks, insurance
companies or other lenders or investors (not including us or any
Restricted Subsidiary), then within 360 days after), the completion of
the acquisition, construction or improvement of such Principal Property
to secure or provide for the payment of any part of the purchase price
of such property or the cost of such construction or improvement, or
liens on any Principal Property existing at the time of acquisition
thereof; |
5
|
(ii) |
|
liens on property or shares of capital stock or
indebtedness of a corporation existing at the time such corporation is
merged into or consolidated with us or a Restricted Subsidiary or at
the time of a sale, lease or other disposition of the properties of a
corporation substantially as an entirety to us or a Restricted
Subsidiary; |
|
|
(iii) |
|
liens on property or shares of capital stock
or indebtedness of a corporation existing at the time such corporation
becomes a Restricted Subsidiary; |
|
|
(iv) |
|
liens to secure indebtedness of a Restricted
Subsidiary to us or to another Restricted Subsidiary, but only so long
as such indebtedness is held by us or a Restricted Subsidiary; |
|
|
(v) |
|
liens in favor of the United States of America
or any State thereof, or any department, agency or political
subdivision of the United States of America or any State thereof, to
secure certain payments pursuant to any contract or statute, including
liens to secure indebtedness of the pollution control or industrial
revenue bond type, or to secure indebtedness incurred for the purpose
of financing all or any part of the purchase price or cost of
constructing or improving property subject to such liens; |
|
|
(vi) |
|
liens in favor of any customer arising in
respect of certain payments made by or on behalf of such customer for
goods produced for or services rendered to such customer in the
ordinary course of business not exceeding the amount of such payments; |
|
|
(vii) |
|
liens to extend, renew or replace in whole or
in part any lien referred to in the foregoing clauses (1) to (6), or in
this clause (7), or any lien created prior to and existing on the date
of the Indenture, provided that the principal amount of indebtedness
secured thereby shall not exceed the principal amount of indebtedness
so secured at the time of such extension, renewal or replacement, and
that such extension, renewal or replacement shall be limited to all or
a part of the property subject to the lien so extended, renewed or
replaced (plus improvements on such property); and |
|
|
(viii) |
|
certain statutory liens, liens for taxes and certain other liens. |
|
|
|
|
(Section 3.6) |
Limitations on Sale and Lease-Back Transactions Subject to the exceptions set forth below
under Exempted Indebtedness, sale and lease-back transactions by us or any Restricted Subsidiary
of any Principal Property which has been owned and operated by us or a Restricted Subsidiary for
more than 120 days are prohibited unless
|
(i) |
|
the property involved is property which could
be the subject of a lien without equally and ratably securing the debt
securities; |
|
|
(ii) |
|
an amount equal to the Attributable Debt (as
hereinafter defined) of any such sale and lease-back transaction is
applied to the acquisition of another Principal Property of equal or
greater fair market value or to retirement of indebtedness for borrowed
money (including the securities) which by its terms matures on or is
renewable at the option of the obligor to a date more than twelve
months after the creation of such indebtedness; or |
|
|
(iii) |
|
the lease involved is for a term (including
renewals) of not more than three years. |
|
|
|
|
(Section 3.7) |
6
Exempted Indebtedness Either we or a Restricted Subsidiary may create or assume liens and
enter into sale and lease-back transactions, notwithstanding the limitations outlined above,
provided that at the time thereof and after giving effect thereto the aggregate amount of
indebtedness secured by all such liens and Attributable Debt of all such sale and lease-back
transactions outstanding shall not exceed 5% of Consolidated Net Tangible Assets (as hereinafter
defined). (Section 3.8)
Limitations on Mergers, Consolidations and Sales of Assets If, upon our consolidation or
merger with or into any other corporation, or upon any sale, conveyance or lease of substantially
all our properties, any Principal Property would become subject to any lien, we, prior to such
event, will secure the debt securities equally and ratably with any of our other obligations then
entitled thereto by a direct lien on all such Principal Property prior to all other liens other
than any theretofore existing thereon. (Section 3.9)
Certain Definitions
The term Restricted Subsidiary means any Subsidiary
(a) substantially all the property of which is located, or substantially all the
business of which is carried on, within the United States and
(b) which owns or leases a Principal Property.
The term Principal Property means any manufacturing plant, research facility or warehouse
owned or leased by us or any of our subsidiaries which is located within the United States and has
a net book value exceeding the greater of $5,000,000 and 1% of the shareholders equity of our
company and our consolidated subsidiaries, excluding any property which the board of directors by
resolution declares is not of material importance to our total business as consolidated with the
business of our subsidiaries.
The term Attributable Debt means the present value (discounted as provided in the senior
indenture) of the obligation of a lessee for required rental payments for the remaining term of any
lease.
The term Consolidated Net Tangible Assets means at any time the total of all assets
appearing on the most recent consolidated balance sheet of us and our consolidated subsidiaries,
prepared in accordance with generally accepted accounting principles, at our and their net book
values (after deducting related depreciation, depletion, amortization and all other valuation
reserves which, in accordance with such principles, are set aside in connection with the business
conducted), but excluding goodwill, trademarks, patents, unamortized debt discount and all other
like segregated intangible assets, and amounts on the asset side of such balance sheet for our
capital stock, all as determined in accordance with such principles, less Consolidated Current
Liabilities.
The term Consolidated Current Liabilities means the aggregate of the current liabilities of
us and our consolidated subsidiaries appearing on the consolidated balance sheet of our company and
our consolidated subsidiaries, all as determined in accordance with generally accepted accounting
principles.
(Section 1.1)
Other than the restrictions on liens and sale and lease-back transactions described above,
neither the Indenture nor the debt securities afford you protection in the event of a highly
leveraged transaction involving us or any of our subsidiaries, including any takeover,
recapitalization or other restructuring that may result in a sudden and significant decline in
credit rating.
Events of Default, Waiver and Notice
As to any series of securities, an event of default is defined in the Indenture as being any
of the following events:
|
(i) |
|
default for 30 days in the payment of any
interest on the securities of such series; |
|
|
(ii) |
|
default in the payment of principal or premium
due on the securities of any series; |
7
|
(iii) |
|
default in the payment of any sinking fund
installment on the securities of such series, when due; |
|
|
(iv) |
|
our default for 90 days in the performance of
any other of the covenants or agreements in the Indenture (other than
those set forth exclusively in the terms of any other series of
securities); |
|
|
(v) |
|
certain events of bankruptcy, insolvency and
reorganization of our company; or |
|
|
(vi) |
|
any other events as may be established in any
applicable supplement. |
|
|
|
|
(Section 5.1) |
No event of default with respect to any particular series of securities necessarily
constitutes an event of default with respect to any other series of securities. (Section 5.11)
The trustee must give notice of a default to the holders of the series of debt securities on
which the default exists within 90 days unless the default is cured or waived. However, the
trustee may withhold this notice if the trustee considers it in the interest of the holders of
securities of such series to do so. The trustee may not withhold notice in the event of a payment
default with regard to principal, interest or a sinking fund. (Section 5.11)
If an event of default has occurred and is continuing:
|
|
|
as described in clause (1), (2) or (3) above, either the trustee or the
holders of 25% in principal amount of the securities of such series then
outstanding may declare the principal (or, in the case of discounted
securities, the amount specified in the terms thereof) of all such securities
to be due and payable immediately. |
|
|
|
|
as described in clause (4) or (5) above, either the trustee or the holders
of not less than 25% in principal amount of all affected securities, voting as
a single class, may declare the principal (or, in the case of discounted
securities, the amount specified in the terms thereof) of all securities to be
due and payable immediately. |
However, upon certain conditions past defaults as described in clause (4) or (5) above may be
waived by the holders of a majority in principal amount of the affected securities then
outstanding, except for defaults in
|
|
|
the payment of principal of, or any premium or interest on, such securities
or |
|
|
|
|
with respect to any covenant or provision which may not be amended without
the approval of each holder affected. |
|
|
|
|
(Sections 5.1 and 5.10) |
The holders of a majority in principal amount of the securities of each series affected,
voting as a separate class, may direct the time, method and place of conducting any proceeding for
any remedy available to the trustee under the Indenture, subject to certain limitations specified
in the Indenture, provided that the holders of securities shall have offered to the trustee
reasonable indemnity against costs, expenses and liabilities. (Sections 5.9 and 6.2(d)) We must
certify to the trustee on a yearly basis as to the absence of certain defaults. (Section 3.5)
Modification of the Indenture
Together with the trustee, and subject to the consent of the holders of at least 66 2/3% of
the outstanding principal amount of the outstanding debt securities of all affected series, we may
modify the Indenture or any supplement to the Indenture. Without the consent of each affected
holder, we may not:
|
(i) |
|
extend the final maturity of any security; |
|
|
(ii) |
|
reduce the principal amount or rate of interest of any security; |
8
|
(iii) |
|
extend the time of payment of interest of any security; |
|
|
(iv) |
|
reduce the amount payable upon the redemption of any security; |
|
|
(v) |
|
reduce the amount of the principal of a
discounted security payable upon acceleration of the maturity of the
security or in the event of bankruptcy; |
|
|
(vi) |
|
impair the right to institute suit to enforce
payment or repayment; or |
|
|
(vii) |
|
change the provisions in the indenture that
relate to its modification or amendment. |
|
|
|
|
(Section 8.2) |
Concerning the Trustee
The Bank of New York Mellon Trust Company, N.A., the trustee under the Indenture, also
performs certain cash management services for, and provides certain credit facilities to, us in the
normal course of business.
Defeasance of the Indenture and Securities
We may, at any time, satisfy our obligations with respect to any payments of principal,
premium or interest of any security or securities of any series by depositing in trust with the
trustee:
(a) money (in the currency in which the securities are payable),
(b) in the case of securities denominated in U.S. dollars, U.S. Government Obligations
(as defined in the Indenture), or a combination of U.S. Government Obligations and money, or
(c) in the case of securities denominated in a foreign currency, Foreign Government
Securities (as defined in the Indenture) or a combination of Foreign Government Securities
and money.
If the deposit is sufficient to make all payments of interest, principal and premium when due,
our obligations with respect to such securities will be discharged and terminated (except as to
certain of our obligations to the trustee), and you will able to look only to the trust fund for
any payment of principal, premium and interest on securities of such series until maturity or
redemption. (Article Ten)
Under United States Federal income tax law, any deposit as described just above is viewed as a
taxable exchange of the securities deposited in the trust for interests in, or for an instrument
representing indebtedness of, the trust. Accordingly, at such time as we may elect to deposit
securities in a trust as described above, you would be required to recognize taxable gain or loss
as if the securities had been sold for an amount equal to the sum of the amount of money and the
fair market value of the securities held in the trust (or, alternatively, the value of the
instrument). You then may be required to include in taxable income your share of the income, gain
and loss of the trust.
Alternatively, the trust might be considered a separate taxable entity, in which case you
might also be taxable on original issue discount as well as interest on the instrument. You should
consult your own advisors with respect to the more detailed tax consequences of such deposit and
discharge, including possible liabilities with regard to tax laws other than United States Federal
income tax law.
Global Securities
We may issue the debt securities of a series in whole or in part in the form of one or more
global certificates that will be deposited with a depositary we will identify in a prospectus
supplement. We will describe the specific terms of the depositary arrangement with respect to a
series of debt securities in the accompanying prospectus supplement.
Upon the issuance of a global security, the depositary will credit, on its book-entry
registration and transfer system, the respective principal amounts of that global security to the
accounts of participants in the
9
depositary. Ownership of beneficial interests in a global security will be limited to
participants or persons that hold interests through participants.
So long as the depositary for a global security, or its nominee, is the registered owner of
the global security, the depositary or its nominee, as the case may be, will be considered the sole
owner or holder of the securities represented by that global security. Except as provided in the
indenture, owners of beneficial interests in securities represented by a global security will not
(a) be entitled to have such securities registered in their names,
(b) receive or be entitled to receive physical delivery of certificates representing
such securities in definitive form,
(c) be considered the owners or holders thereof under the Indenture or
(d) have any rights under the Indenture.
We may, in our sole discretion, at any time determine that any series of securities issued or
issuable in the form of a global security shall no longer be represented by such global security
and such global security shall be exchanged for securities in definitive form pursuant to the
Indenture.
(Section 2.14)
Preferred Stock
The following is a description of general terms and provisions of the preferred stock. The
particular terms of any series of preferred stock will be described in the applicable prospectus
supplement.
All of the terms of the preferred stock are, or will be, contained in our Restated Certificate
of Incorporation and the certificate of amendment relating to each series of the preferred stock,
which will be filed with the SEC at or prior to the time of issuance of the series of the preferred
stock.
We are authorized to issue up to 25,000,000 shares of preferred stock, par value $1.00 per
share. As of November 26, 2008, no shares of preferred stock were outstanding. Subject to
limitations prescribed by law, the board of directors is authorized at any time to issue one or
more series of preferred stock.
The board of directors is authorized to determine, for each series of preferred stock, and the
prospectus supplement will set forth with respect to the series the following information:
|
|
|
the designation for any series by number, letter or title that shall
distinguish the series from any other series of preferred stock; |
|
|
|
|
the number of shares in any series; |
|
|
|
|
whether dividends on that series of preferred stock will be cumulative; |
|
|
|
|
the dividend rate (or method for determining the rate); |
|
|
|
|
any liquidation preference per share of that series of preferred stock; |
|
|
|
|
any conversion provisions applicable to that series of preferred stock; |
|
|
|
|
any redemption or sinking fund provisions applicable to that series of
preferred stock; |
|
|
|
|
any voting rights of that series of preferred stock; and the terms of any
other preferences or rights applicable to that series of preferred stock. |
The preferred stock, when issued, will be fully paid and non-assessable.
10
Dividends
Holders of preferred stock will be entitled to receive, when, as and if declared by the board
of directors, cash dividends at the rates and on the dates as set forth in the prospectus
supplement. Generally, no dividends will be declared or paid on any series of preferred stock
unless full dividends for all series of preferred stock, including any cumulative dividends still
owing, have been or contemporaneously are declared and paid. When those dividends are not paid in
full, dividends will be declared pro-rata so that the amount of dividends declared per share on
each series of preferred stock will bear to each other series the same ratio that accrued dividends
per share for each respective series of preferred stock bear to aggregate accrued dividends for all
outstanding shares of preferred stock. In addition, generally, unless all dividends on the
preferred stock have been paid, no dividends will be declared or paid on the common stock and we
may not redeem or purchase any common stock.
Payment of dividends on any series of preferred stock may be restricted by loan agreements,
indentures and other transactions we may enter into.
Liquidation
If we voluntarily or involuntarily liquidate, dissolve or wind up our affairs, the holders of
each series of preferred stock will be entitled to receive the liquidation preference per share
specified in the prospectus supplement plus any accrued and unpaid dividends. Holders of preferred
stock will be entitled to receive these amounts before any distribution is made to the holders of
common stock. If the amounts payable with respect to preferred stock are not paid in full, the
holders of preferred stock will share ratably in any distribution of assets based upon the
aggregate liquidation preference for all outstanding shares for each series. After the holders of
shares of preferred stock are paid in full, they will have no right or claim to any of our
remaining assets.
Neither the par value nor the liquidation preference is indicative of the price at which the
preferred stock will actually trade on or after the date of issuance.
Voting
Generally, the holders of preferred stock will not be entitled to vote except as set forth in
the prospectus supplement, the Restated Certificate of Incorporation or certificate of amendment or
as otherwise required by law.
No Other Rights
The shares of a series of preferred stock will not have any preemptive rights, preferences,
voting powers or relative, participating, optional or other special rights except as set forth in
the prospectus supplement, the Restated Certificate of Incorporation or certificate of amendment or
as otherwise required by law.
Transfer Agent and Registrar
The transfer agent for each series of preferred stock will be designated in the prospectus
supplement.
Depositary Shares
We may, at our option, elect to offer fractional shares of preferred stock, rather than full
shares of preferred stock. If we do, we will issue to the public receipts for depositary shares
and each of these depositary shares will represent a fraction of a share of a particular series of
preferred stock. Each owner of a depositary share will be entitled, in proportion to the
applicable fractional interest in shares of preferred stock underlying that depositary share, to
all rights and preferences of the preferred stock underlying that depositary share. Those rights
include dividend, voting, redemption and liquidation rights.
The shares of preferred stock underlying the depositary shares will be deposited with a
depositary under a deposit agreement between us, the depositary and the holders of the depositary
receipts evidencing the depositary shares. The depositary will be a bank or trust company selected
by us. The depositary will also act as the transfer agent, registrar and dividend disbursing agent
for the depositary shares.
11
Holders of depositary receipts agree to be bound by the deposit agreement, which requires
holders to take certain actions such as filing proof of residence and paying certain charges.
The following is a summary of the most important terms of the depositary shares. The deposit
agreement, our Restated Certificate of Incorporation and the certificate of amendment for the
applicable series of preferred stock that are, or will be, filed with the SEC will set forth all of
the terms relating to the depositary shares.
Dividends
The depositary will distribute all cash dividends or other cash distributions received in
respect of the series of preferred stock underlying the depositary shares to the record holders of
depositary receipts in proportion to the number of depositary shares owned by those holders on the
relevant record date. The record date for the depositary shares will be the same date as the
record date for the preferred stock.
In the event of a distribution other than in cash, the depositary will distribute property
received by it to the record holders of depositary receipts that are entitled to receive the
distribution. However, if the depositary determines that it is not feasible to make the
distribution, the depositary may, with our approval, adopt another method for the distribution.
The method may include selling the property and distributing the net proceeds to the holders.
Liquidation Preference
In the event of our voluntary or involuntary liquidation, dissolution or winding up, the
holders of each depositary share will be entitled to receive the fraction of the liquidation
preference accorded each share of the applicable series of preferred stock, as set forth in the
applicable prospectus supplement.
Redemption
If a series of preferred stock underlying the depositary shares is subject to redemption, the
depositary shares will be redeemed from the proceeds received by the depositary resulting from the
redemption, in whole or in part, of preferred stock held by the depositary. Whenever we redeem any
preferred stock held by the depositary, the depositary will redeem, as of the same redemption date,
the number of depositary shares representing the preferred stock so redeemed. The depositary will
mail the notice of redemption to the record holders of the depositary receipts promptly upon
receiving the notice from us and not less than 35 nor more than 60 days prior to the date fixed for
redemption of the preferred stock and the depositary shares.
Voting
Upon receipt of notice of any meeting at which the holders of preferred stock are entitled to
vote, the depositary will mail the information contained in the notice of meeting to the record
holders of the depositary receipts underlying the preferred stock. Each record holder of those
depositary receipts on the record date will be entitled to instruct the depositary as to the
exercise of the voting rights pertaining to the amount of preferred stock underlying that holders
depositary shares. The record date for the depositary shares will be the same date as the record
date for the preferred stock. The depositary will try, as far as practicable, to vote the
preferred stock underlying the depositary shares in accordance with the instructions of the holders
of the depositary receipts. We will agree to take all action which may be deemed necessary by the
depositary in order to enable the depositary to do so. The depositary will not vote the preferred
stock to the extent that it does not receive specific instructions from the holders of depositary
receipts.
Withdrawal of Preferred Stock
Owners of depositary shares are entitled, upon surrender of depositary receipts at the
principal office of the depositary and payment of any unpaid amount due the depositary, to receive
the number of whole shares of preferred stock underlying the depositary shares. Partial shares of
preferred stock will not be issued. These holders of preferred stock will not be entitled to
deposit the shares under the deposit agreement or to receive depositary receipts evidencing
depositary shares for the preferred stock.
12
Amendment and Termination of Deposit Agreement
The form of depositary receipt evidencing the depositary shares and any provision of the
deposit agreement may be amended at any time and from time to time by agreement between us and the
depositary. However, any amendment which materially and adversely alters the rights of the holders
of depositary shares, other than any change in fees, will not be effective unless the amendment has
been approved by at least a majority of the depositary shares then outstanding. The deposit
agreement may be terminated by us or the depositary only if:
|
|
|
all outstanding depositary shares have been redeemed or |
|
|
|
|
there has been a final distribution in respect of the preferred stock in
connection with our dissolution and such distribution has been made to all the
holders of depositary shares. |
Charges of Depositary
We will pay all transfer and other taxes and governmental charges arising solely from the
existence of the depositary arrangements. We will also pay charges of the depositary in connection
with the initial deposit of the preferred stock and the initial issuance of the depositary shares,
any redemption of the preferred stock and all withdrawals of preferred stock by owners of
depositary shares. Holders of depositary receipts will pay transfer, income and other taxes and
governmental charges and certain other charges as provided in the deposit agreement to be for their
accounts. In certain circumstances, the depositary may refuse to transfer depositary shares, may
withhold dividends and distributions and sell the depositary shares evidenced by the depositary
receipt if the charges are not paid.
Reports to Holders
The depositary will forward to the holders of depositary receipts all reports and
communications we deliver to the depositary that we are required to furnish to the holders of the
preferred stock. In addition, the depositary will make available for inspection by holders of
depositary receipts at the principal office of the depositary, and at other places as it may from
time to time deem advisable, any reports and communications we deliver to the depositary as the
holder of preferred stock.
Liability and Legal Proceedings
Neither we nor the depositary will be liable if either of us are prevented or delayed by law
or any circumstance beyond our control in performing our respective obligations under the deposit
agreement. Our obligations and those of the depositary will be limited to performance in good
faith of our respective duties under the deposit agreement. Neither we nor the depositary will be
obligated to prosecute or defend any legal proceeding in respect of any depositary shares or
preferred stock unless satisfactory indemnity is furnished. We and the depositary may rely on
written advice of counsel or accountants, on information provided by holders of depositary receipts
or other persons believed in good faith to be competent to give such information and on documents
believed to be genuine and to have been signed or presented by the proper party or parties.
Resignation and Removal of Depositary
The depositary may resign at any time by delivering a notice to us of its election to do so.
We may remove the depositary at any time. Any such resignation or removal will take effect upon
the appointment of a successor depositary and its acceptance of such appointment. The successor
depositary must be appointed within 60 days after delivery of the notice for resignation or
removal. In addition, the successor depositary must be a bank or trust company having its
principal office in the United States of America and having a combined capital and surplus of at
least $150,000,000.
13
United States Federal Income Tax Consequences
Owners of the depositary shares will be treated for United States Federal income tax purposes
as if they were owners of the preferred stock underlying the depositary shares. Accordingly, the
owners will be entitled to take into account for United States Federal income tax purposes income
and deductions to which they would be entitled if they were holders of the preferred stock. In
addition:
|
|
|
no gain or loss will be recognized for United States Federal income tax
purposes upon the withdrawal of preferred stock in exchange for depositary
shares; |
|
|
|
|
the tax basis of each share of preferred stock to an exchanging owner of
depositary shares will, upon the exchange, be the same as the aggregate tax
basis of the depositary shares exchanged; and the holding period for
preferred stock in the hands of an exchanging owner of depositary shares will
include the period during which the person owned the depositary shares. |
Common Stock
As of the date of this prospectus, we are authorized to issue up to 300,000,000 shares of
common stock, $1.00 par value per share. As of November 17, 2008, 209,566,838 shares of common
stock were outstanding.
Dividends
Holders of common stock are entitled to receive dividends, in cash, securities, or property,
as may from time to time be declared by our board of directors, subject to the rights of the
holders of the preferred stock.
Voting
Each holder of common stock is entitled to one vote per share on all matters requiring a vote
of the stockholders.
Rights Upon Liquidation
In the event of our voluntary or involuntary liquidation, dissolution, or winding up, the
holders of common stock will be entitled to share equally in our assets available for distribution
after payment in full of all debts and after the holders of preferred stock have received their
liquidation preferences in full.
Miscellaneous
Shares of common stock are not redeemable and have no subscription, conversion or preemptive
rights.
Warrants
We may issue warrants for the purchase of debt securities, preferred stock or common stock.
Warrants may be issued independently or together with our debt securities, preferred stock or
common stock and may be attached to or separate from any offered securities. Each series of
warrants will be issued under a separate warrant agreement to be entered into between us and a bank
or trust company, as warrant agent. The warrant agent will act solely as our agent in connection
with the warrants and will not have any obligation or relationship of agency or trust for or with
any holders or beneficial owners of warrants. A copy of the warrant agreement will be filed with
the SEC in connection with the offering of warrants.
The prospectus supplement relating to a particular issue of warrants will describe the terms
of those warrants, including the following:
|
|
|
the title of the warrants; |
|
|
|
|
any offering price for the warrants; |
14
|
|
|
the aggregate number of the warrants; |
|
|
|
|
the designation and terms of the securities that may be purchased upon
exercise of the warrants; |
|
|
|
|
if applicable, the designation and terms of the securities together with
which the warrants are issued and the number of warrants issued with each
security; |
|
|
|
|
any date from and after which the warrants and any securities issued with
them will be separately transferable; |
|
|
|
|
the principal amount of or number of shares of stock that may be purchased
upon exercise of a warrant and the price at which the debt securities may be
purchased upon exercise; |
|
|
|
|
the dates on which the right to exercise the warrants will commence and
expire; |
|
|
|
|
any minimum or maximum amount of the warrants that may be exercised at any
one time; |
|
|
|
|
the currency or currency units in which the offering price and the exercise
price are payable; |
|
|
|
|
if applicable, a discussion of material United States Federal, or other
income tax considerations; |
|
|
|
|
any antidilution provisions of the warrants; |
|
|
|
|
any redemption or call provisions applicable to the warrants; |
|
|
|
|
any additional terms of the warrants, including terms, procedures, and
limitations relating to the exchange and exercise of the warrants; |
|
|
|
|
whether the warrants represented by the warrant certificates or debt
securities that may be issued upon exercise of the warrants will be issued in
registered or bearer form; and any information with respect to book-entry
procedures. |
PLAN OF DISTRIBUTION
We may sell the securities in any of four ways:
|
(i) |
|
directly to purchasers; |
|
|
(ii) |
|
through underwriters; or |
|
|
(iii) |
|
through agents; |
|
|
(iv) |
|
through dealers. |
We may solicit offers to purchase securities directly or by the means of designated agents
from time to time. Any such agent, who may be deemed to be an underwriter as that term is defined
in the Securities Act of 1933, involved in the offer or sale of the securities in respect of which
this prospectus is delivered will be named, and any commissions payable by us to such agent will be
set forth, in the prospectus supplement. Unless otherwise indicated in the prospectus supplement,
any such agent will be acting on a best efforts basis for the period of its appointment. Agents
may be customers of, engage in transactions with, or perform services for, us in the ordinary
course of business.
15
LEGAL OPINIONS
The legality of the securities in respect of which this Prospectus is being delivered will be
passed on for us by Ann E. Padjen, Esq., Corporate and Finance Counsel for the Company and for any
underwriters by Cravath, Swaine & Moore LLP, Worldwide Plaza, 825 Eighth Avenue, New York, New York
10019. We pay a salary to Ms. Padjen in her indicated capacity, she is a participant in various
employee benefit plans offered to our employees generally, and she owns shares of our common stock
and participates in our long-term incentive program, which entitles executives to stock options and
deferred stock units. Cravath, Swaine & Moore LLP from time to time acts as special counsel for
the Company.
EXPERTS
The consolidated financial statements and
schedule of Air Products and Chemicals, Inc. (the Company) as of 30
September 2008 and 2007, and for each of the years in the three-year period
ended 30 September 2008, and managements assessment of the
internal control over financial reporting as of 30 September 2008
have been incorporated by reference herein in reliance of the reports
of KPMG LLP, independent registered public accounting firm,
incorporated by reference herein, and upon the authority of said firm
as experts in accounting and auditing.
The audit report covering the 30 September
2008 consolidated financial statements refers to the Companys adoption of
Financial Accounting Standards Board (FASB) Interpretation No. 48.
Accounting for Uncertainty in Income Taxes, effective 1
October 2007; Statement of Financial Accounting Standards No. 158,
Employers Accounting for Defined Benefit Pension and
Other Postretirement Plans, as of 30 September 2007; and FASB
Interpretation No. 47, Accounting for Conditional Asset
Retirement Obligations, effective 30 September 2006.
PART II. INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
|
|
|
|
|
Registration Fee |
|
$ |
* |
|
Printing Fees |
|
|
15,000 |
|
Accountants Fees |
|
|
10,000 |
|
Rating Agency Fees |
|
|
500,000 |
|
Fees and Expenses of trustee |
|
|
10,000 |
|
Miscellaneous |
|
|
15,000 |
|
Total |
|
$ |
550,000 |
|
|
|
|
* |
|
In accordance with Rule 456(b), we are deferring payment of the registration fee for the
securities offered by this prospectus. |
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Section 145 of the Delaware Corporation Law gives corporations the power to indemnify officers
and directors under certain circumstances.
Article Ninth of our Restated Certificate of Incorporation contains provisions which provide
for indemnification of certain persons (including officers and directors). The Restated
Certificate of Incorporation is filed as an exhibit to our Annual Report on Form 10-K for the
fiscal year ended September 30, 1987.
We maintain insurance that generally insures our officers and directors and the officers and
directors of our subsidiaries (as defined in the insurance policy) against liabilities incurred in
their professional capacities, and insures us with respect to amounts to which officers and
directors become entitled as indemnification payments from us, subject to certain specified
exclusions and deductible and maximum amounts. We also maintain an insurance policy that protects,
among others, certain of our officers and directors and certain of the officers and directors of
our subsidiaries against liabilities incurred for Breach of Fiduciary Duty (as defined in the
insurance policy) with respect to their performance of their duties and responsibilities in
connection with certain of our pension and retirement plans, or the plans of certain of our
subsidiaries, subject to certain specified exclusions and deductible and maximum amounts.
ITEM 16. EXHIBITS.
The following Exhibits are filed as part of this Registration Statement:
|
|
|
Exhibit 1.1
|
|
Form of Agency Agreement. (Incorporated by reference to Exhibit 1 to
the Companys Registration Statement No. 333-33851.) |
|
|
|
Exhibit 1.2 |
|
Form of Underwriting Agreement for Debt Securities. |
|
|
|
Exhibit 3.1
|
|
By-Laws As Amended and Restated of the Company effective November 20,
2008. (Incorporated by reference to Exhibit 99.1 to the Companys Form
8-K Report dated November 24, 2008.) |
|
|
|
Exhibit 3.2
|
|
Restated Certificate of Incorporation of the Company. (Incorporated by
reference to Exhibit 3.2 to the Companys Form 10-K Report for the
fiscal year ended September 30, 1987.) |
|
|
|
Exhibit 3.3
|
|
Amendment to the Restated Certificate of Incorporation of the Company
dated January 25, 1996. (Incorporated by reference to Exhibit 3.3 to
the Companys Form 10-K Report for the fiscal year ended September 30
1996.) |
|
|
|
Exhibit 4.1
|
|
Indenture dated as of January 10, 1995, between the Company and Wachovia
Bank, National Association (formerly, First Fidelity Bank, National
Association), as Trustee. (Incorporated by reference to Exhibit 4(a) to
the Companys Registration Statement No. 33-57357.) |
II-1
|
|
|
Exhibit 4.2
|
|
Form of Fixed Rate Medium-Term Note. (Incorporated by reference to
Exhibit 4(b) to the Companys Registration Statement No. 333-33851.) |
|
|
|
Exhibit 4.3
|
|
Form of Floating Rate Medium-Term Note. (Incorporated by reference to
Exhibit 4(c) to the Companys Registration Statement No. 333-33851.) |
|
|
|
Exhibit 4.4
|
|
Form of Fixed Rate Currency Indexed Medium-Term Note. (Incorporated by
reference to Exhibit 4(d) to the Companys Registration Statement No.
333-33851.) |
|
|
|
Exhibit 4.5
|
|
Form of S&P 500 Linked Medium-Term Note. (Incorporated by reference to
Exhibit 4(e) to the Companys Registration Statement No. 333-33851.) |
|
|
|
Exhibit 4.6
|
|
Form of senior debt security (contained in Exhibit 4.1). |
|
|
|
Exhibit 4.7
|
|
Form of Preferred Stock Certificate. (To be filed as an exhibit to a
current report of the Company and incorporated by reference in this
registration statement) |
|
|
|
Exhibit 4.8
|
|
Form of Deposit Agreement. (To be filed as an exhibit to a current
report of the Company and incorporated by reference in this registration
statement) |
|
|
|
Exhibit 4.9
|
|
Form of Deposit Receipt. (To be filed as an exhibit to a current report
of the Company and incorporated by reference in this registration
statement) |
|
|
|
Exhibit 4.10
|
|
Form of Warrant Agreement. (To be filed as an exhibit to a current
report of the Company and incorporated by reference in this registration
statement) |
|
|
|
Exhibit 4.11
|
|
Form of Warrant Certificate. (To be filed as an exhibit to a current
report of the Company and incorporated by reference in this registration
statement) |
|
|
|
Exhibit 4.12
|
|
Rights Agreement, dated as of 19 March 1998, between the Company and
First Chicago Trust Company of New York. (Incorporated by reference to
Exhibit 1 to the Companys Form 8-A Registration Statement dated 19
March 1998, as amended by Form 8-A/A dated 16 July 1998.) |
|
|
|
Exhibit 5
|
|
Opinion of Company counsel as to legality of the securities to be issued. |
|
|
|
Exhibit 12
|
|
Computation of Ratios of Earnings to Fixed Charges
(Incorporated by reference to Exhibit [ ] to the Companys Annual Report
on Form 10-K for the year ended September 30, 2008.) |
|
|
|
Exhibit 23.1
|
|
Consent of KPMG LLP. |
|
|
|
Exhibit 23.2
|
|
Consent of Company counsel (contained in Exhibit 5). |
|
|
|
Exhibit 24
|
|
Power of Attorney. |
|
|
|
Exhibit 25
|
|
Form T-1 Statement of Eligibility and Qualification under the Trust
Indenture Act of 1939 of The Bank of New York Mellon Trust Company,
N.A., as trustee under the senior indenture. |
II-2
ITEM 17. UNDERTAKINGS.
The undersigned registrant hereby undertakes:
(2) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) To include any prospectus required by section 10(a)(3) of the Securities Act of
1933;
(ii) To reflect in the prospectus any facts or events arising after the effective date
of this registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this registration statement. Notwithstanding the foregoing, any increase or
decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of prospectus filed with
the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than a 20% change in the maximum aggregate offering price set forth in the
Calculation of Registration Fee table in the effective registration statement;
(iii) To include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such
information in this registration statement;
(3) That, for the purpose of determining any liability under the Securities Act of 1933, each
such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(4) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(5) That, for the purpose of determining liability under the Securities Act of 1933 to any
purchaser:
(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed
to be part of the registration statement as of the date the filed prospectus was deemed part
of and included in the registration statement; and
(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7)
as part of a registration statement in reliance on Rule 430B relating to an offering made
pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information
required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and
included in the registration statement as of the earlier of the date such form of prospectus
is first used after effectiveness or the date of the first contract of sale of securities in
the offering described in the prospectus. As provided in Rule 430B, for liability purposes
of the issuer and any person that is at that date an underwriter, such date shall be deemed
to be a new effective date of the registration statement relating to the securities in the
registration statement to which that prospectus relates, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. Provided,
however, that no statement made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or deemed incorporated by
reference into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or
prospectus that was part of the registration statement or made in any such document
immediately prior to such effective date.
(6) That, for the purpose of determining liability of the registrant under the Securities Act
of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant
undertakes that in a primary offering of securities of the undersigned registrant pursuant to this
registration statement, regardless of the underwriting method used to sell the securities to the
purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered
to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to
the offering required to be filed pursuant to Rule 424;
II-3
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of
the undersigned registrant or used or referred to by the undersigned registrant;
(iii) The portion of any other free writing prospectus relating to the offering
containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and
(iv) Any other communication that is an offer in the offering made by the undersigned
registrant to the purchaser.
(7) The undersigned registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrants annual report pursuant
to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plans annual report pursuant to section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
(8) The undersigned registrant hereby undertakes to file an application for the purpose of
determining the eligibility of the trustee to act under Subsection (a) of section 310 of the Trust
Indenture Act (the Act) in accordance with the rules and regulations prescribed by the
Commission under section 305(b)(2) of the Act.
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with
the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Allentown and Commonwealth of Pennsylvania on the 26th
day of November, 2008.
|
|
|
|
|
|
|
|
|
|
|
AIR PRODUCTS AND CHEMICALS, INC.
|
|
|
|
|
|
|
(Issuer) |
|
|
|
|
|
|
|
|
|
|
|
By
|
|
/s/ Paul E. Huck |
|
|
|
|
|
|
|
|
|
|
|
|
|
(Paul E. Huck, Senior Vice President and |
|
|
|
|
|
|
Chief Financial Officer) |
|
|
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
been signed below by the following persons in the capacities indicated on November 26, 2008.
|
|
|
SIGNATURE |
|
TITLE |
|
|
Director and Chairman; |
/s/ John E. McGlade |
|
President and Chief Executive Officer |
|
|
|
(John E. McGlade) |
|
|
|
|
|
/s/ Paul E. Huck |
|
Senior Vice President and Chief Financial Officer |
|
|
|
(Paul E. Huck) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Mario L. Baeza) |
|
|
|
|
|
* |
|
Director |
|
|
|
(William L. Davis, III) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Michael J. Donahue) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Ursula F. Fairbairn) |
|
|
|
|
|
* |
|
Director |
|
|
|
(W. Douglas Ford) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Edward E. Hagenlocker)) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Evert Henkes) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Margaret G. McGlynn) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Charles H. Noski) |
|
|
|
|
|
* |
|
Director |
|
|
|
(Lawrence S. Smith) |
|
|
|
|
|
* |
|
Steven J. Jones, Senior Vice President, General Counsel and Secretary, by signing his name
hereto, does sign this document on behalf of the above noted individuals, pursuant to a power
of attorney duly executed by such individuals which is filed with the Securities and Exchange
Commission herewith. |
|
|
|
|
|
|
|
|
|
|
|
/s/ Stephen J. Jones
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Stephen J. Jones, Attorney-in-Fact) |
|
|
II-5